Rare Diseases & Orphan drugs
Rare diseases are life-threatening or chronically debilitating conditions, affecting no more than 5 in 10,000 persons in the European Community according to the Regulation (EC) N. 141/2000 of the European Parliament and of the Council. It is estimated that between 6000 to 8000 distinct rare diseases affect up to 6% of the total EU population. Therefore, these conditions can be considered rare if taken individually but they affect a significant proportion of the European population when considered as a single group. Several initiatives have been taken at international, European and national level to tackle public health as well as research issues related to diagnosis, prevention, treatment and surveillance of these diseases. An Orphan drug can be defined as the one that is used to treat an orphan disease. An orphan disease in USA is defined as the one that affects fewer than 200000 individuals, but in Japan the number is 50,000 and in Australia is 2000. In past 20 years efforts have been made to encourage companies to develop orphan drugs. The Orphan Drug Act in the USA (1983) was succeeded by similar legislation in Japan (1985), Australia (1997), and the European Community (2000). The encouragement takes three forms: tax credits and research aids, simplification of marketing authorization procedures, and extended market exclusively.
- Craniofacial Morphogenesis
- Diverse Immunotherapy Approaches
- T cell immunotherapy
- Gene, stem cell and future therapies for orphan diseases
- Rare Diseases and Regenerative Medicine
Related Conference of Rare Diseases & Orphan drugs
14th International Conference on Human Genetics and Genetic Diseases
Rare Diseases & Orphan drugs Conference Speakers
Recommended Sessions
- Advances in Biomedical Engineering, Imaging and Screening
- Cell & Gene Therapy Development & Production
- Cell Therapy
- Cell Therapy Bioprocessing
- Cellular and Technological Breakthroughs in Cancer
- Clinical and Translational Research
- Gene Therapy
- Genetic Medicine
- Immunotherapy
- Molecular Medicine
- Nuclear Medicine
- Rare Diseases & Orphan drugs
- Stem Cell Research and Regenerative Medicine
- Synthetic Biology and CRISPR Technology
- Technologies in Stem Cell Research
Related Journals
Are you interested in
- 3D Bio-Printing and Organ Printing - Stemgen 2024 (UK)
- 3D bioprinting using Stem Cells - Stemgen 2024 (UK)
- Advanced Gene Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Advances in Cell Therapy Research - REGENERATIVE MED MEET 2024 (UK)
- Applications of Stem Cells - Stemgen 2024 (UK)
- Applications of Tissue engineering & Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Bio Banking - Stemgen 2024 (UK)
- Bio Banking Stem cell - Stem Cell 2024 (Ireland)
- Biochemical Genetics - Human Genetics 2024 (Canada)
- Bioengineering Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Bioinformatics, Machine learning and Statistical methods - HUMAN GENETICS MEET 2024 (UAE)
- Biologic Scaffolds for Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Biomaterials & Bioengineering - REGENERATIVE MED MEET 2024 (UK)
- Bone Marrow Transplantation - Stem Cell 2024 (Ireland)
- Bone Marrow Transplantation - Stemgen 2024 (UK)
- Cancer Genetics - Human Genetics 2024 (Canada)
- Cancer Stem Cell and Oncology - Stemgen 2024 (UK)
- Cancer Therapies - WORLD CELL THERAPY 2024 (UK)
- Cancer, Cardiovascular Diseases and Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Cell and Gene Therapy - Stemgen 2024 (UK)
- Cell Culture and Bio processing - WORLD CELL THERAPY 2024 (UK)
- Cell Science and Stem Cell Research - WORLD CELL THERAPY 2024 (UK)
- Cell Therapy and Regenerative Medicine Market - REGENERATIVE MED MEET 2024 (UK)
- Cell Therapy in Pulmonology - WORLD CELL THERAPY 2024 (UK)
- Cellular Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Genetics - Human Genetics 2024 (Canada)
- Clinical Genetics and Novel Therapies of Genetic Diseases - HUMAN GENETICS MEET 2024 (UAE)
- Clinical Methods - Stem Cell 2024 (Ireland)
- Clinical Trials and Research in Cell and Gene Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Trials on Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Cytogenetics - Human Genetics 2024 (Canada)
- Dental Stem Cell - Stemgen 2024 (UK)
- Dental Stem Cells - Stem Cell 2024 (Ireland)
- Developmental Genetics - Human Genetics 2024 (Canada)
- Diabetes Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Effect of Aging on Stem Cells - Stemgen 2024 (UK)
- Epigenetics - Human Genetics 2024 (Canada)
- Epigenetics and Gene Regulation - HUMAN GENETICS MEET 2024 (UAE)
- Ethical & Social Implications of Gene Editing - Human Genetics 2024 (Canada)
- Evolutionary and Population Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Functional Genomics and Transcriptomics - HUMAN GENETICS MEET 2024 (UAE)
- Gene Cloning and Mapping - HUMAN GENETICS MEET 2024 (UAE)
- Gene Therapy - Human Genetics 2024 (Canada)
- Gene Therapy - REGENERATIVE MED MEET 2024 (UK)
- Gene Therapy and Genetic Counseling - Human Genetics 2024 (Canada)
- Genetic Counseling - Human Genetics 2024 (Canada)
- Genetic Disorders - Human Genetics 2024 (Canada)
- Genetic Vaccines - WORLD CELL THERAPY 2024 (UK)
- Genomic Medicine & Molecular Diagnostics - Human Genetics 2024 (Canada)
- Genomics - Human Genetics 2024 (Canada)
- HIV Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Genetic Engineering - Human Genetics 2024 (Canada)
- Human genetics - Human Genetics 2024 (Canada)
- Human Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Immunogenetics - Human Genetics 2024 (Canada)
- Immunotherapy - REGENERATIVE MED MEET 2024 (UK)
- Immunotherapy - WORLD CELL THERAPY 2024 (UK)
- Medical Genetics - Human Genetics 2024 (Canada)
- Models of Regeneration - REGENERATIVE MED MEET 2024 (UK)
- Molecular and Cytogenetics - HUMAN GENETICS MEET 2024 (UAE)
- Molecular Effects of Genetic Variation - HUMAN GENETICS MEET 2024 (UAE)
- Molecular Epigenetics - WORLD CELL THERAPY 2024 (UK)
- Molecular Genetics - Human Genetics 2024 (Canada)
- Molecular Phenotyping and Omics Technologies - HUMAN GENETICS MEET 2024 (UAE)
- Mutation Detection and Analysis - HUMAN GENETICS MEET 2024 (UAE)
- Nano-Therapy - WORLD CELL THERAPY 2024 (UK)
- Nanotechnology in Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Nanotechnology in Stem Cell - WORLD CELL THERAPY 2024 (UK)
- Neurodegenerative Disease - Stem Cell 2024 (Ireland)
- New Market Trends, R&D on Stem Cells - Stemgen 2024 (UK)
- Novel Approaches guided in Tissue Engineering - REGENERATIVE MED MEET 2024 (UK)
- Novel Stem Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Nutritional Genomics - Human Genetics 2024 (Canada)
- Oncogenomics and Cancer Heredity - Human Genetics 2024 (Canada)
- Orthopedics, Sports Medicine and Regenerative Rehabilitation - REGENERATIVE MED MEET 2024 (UK)
- Pharmacogenetics - Human Genetics 2024 (Canada)
- Pharmacogenomics - HUMAN GENETICS MEET 2024 (UAE)
- Population Genetics - Human Genetics 2024 (Canada)
- Regeneration and Therapeutics - Stem Cell 2024 (Ireland)
- Regenerative Medicine - Stemgen 2024 (UK)
- Regenerative Medicine in Aging, Dermatology and Plastic Surgery - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine Research - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine research and development - Stemgen 2024 (UK)
- Regenerative Therapy in Osteoarthritis - Stemgen 2024 (UK)
- Research and Development of Stem Cell & Regenerative Drugs - Stem Cell 2024 (Ireland)
- Sickle cell Anaemia Genomics - HUMAN GENETICS MEET 2024 (UAE)
- Skin Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Stem Cell and Tissue Engineering - Stemgen 2024 (UK)
- Stem Cell Animal Applications - Stem Cell 2024 (Ireland)
- Stem Cell Apoptosis and Signal Transmission - Stem Cell 2024 (Ireland)
- Stem Cell Embryology - Stem Cell 2024 (Ireland)
- Stem cell engineering - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Cardiovascular Disease - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Development - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Discovery - Stem Cell 2024 (Ireland)
- Stem Cell Research - Human Genetics 2024 (Canada)
- Stem Cell Research and Therapy - Human Genetics 2024 (Canada)
- Stem Cell Therapies - WORLD CELL THERAPY 2024 (UK)
- Stem Cell Therapy - Stemgen 2024 (UK)
- Stem cell Transplantation - HUMAN GENETICS MEET 2024 (UAE)
- Stem Cell Transplantation - Stem Cell 2024 (Ireland)
- Stem Cell Transplantation to Avoid Cancer - Stemgen 2024 (UK)
- Stem Cells - Stem Cell 2024 (Ireland)
- Stem Cells and Disease Modelling - Stemgen 2024 (UK)
- The use of Stem Cells for COVID-19 Therapy - Stemgen 2024 (UK)
- Theories of Aging in Stem Biology - Stem Cell 2024 (Ireland)
- Tissue Engineering - Stem Cell 2024 (Ireland)
- Tissue Science and Engineering - REGENERATIVE MED MEET 2024 (UK)
- Translational Medicine - HUMAN GENETICS MEET 2024 (UAE)
- Translational Research in Stem Cell Assessments - Stem Cell 2024 (Ireland)
- Viral gene therapy - WORLD CELL THERAPY 2024 (UK)